COMPANY PROFILE · UPDATED 01 AUG 2026

Freenome

Freenome, Inc. provides clinical research services. The Company develops and creates screening, diagnosis, and treatment of age-associated clinical conditions. Freenome serves patients and the healthcare sector in the United States.

freenome.com ↗

This profile is unclaimed — do you work here? Claim it

Claim it →

Founded: 2014
Headcount: 349
Open roles: 27
Last raised: Corporate Round · Sign in to view

TECH STACK

How Freenome builds

Extracted from Freenome’s job postings we’ve tracked

Programming Languages

Python×13 C++×3 Java×2

Cloud Platforms

Google Cloud×7 Microsoft Azure×5 Amazon Web Services×3

DevOps & Infrastructure

Docker×3 Docker/Kubernetes×3 Kubernetes×2 CUDA Git GitHub

Frameworks & Libraries

NumPy×3 pandas×3 CMS

AI & Machine Learning

PyTorch×3 TensorFlow×3 Hugging Face

Analytics & BI

Matplotlib×3

Data Engineering & Warehousing

Apache Airflow

LEADERSHIP

Founders & key people

Gabriel Otte

CEO at ChitChatter

Healthcare Co-opFreenomeGlydeResearch Cornell UniversityFileMakerAppleCornell University

Charles Roberts

CEO at Loxbridge Research

FreenomeRelation TherapeuticsFrameshiftARK Investment ManagementLouvainLoxbridge ResearchUniversity of DundeeUniversity of OxfordUniversity College London (UCL)

Riley Ennis

CEO at Immudicon

OncolinxFreenomeImmudiconThe Thiel FoundationFoundation MedicineSyros PharmaceuticalsJohns Hopkins UniversityYale School of ManagementThomas Jefferson High School for Science and TechnologyDartmouth College

Michael Otte

Vice President at HOMER

HOMERFreelance Software EngineerStanford Health CareStanford UniversityFreenomeAcornDartmouth College

OPEN ROLES

Hiring at Freenome

View all 27 open roles →

FUNDING

Capital raised

Total raised

$2,070,550,000

Investors

Founders Fund Gv Andreessen HorowitzAME Cloud VenturesARK Investment ManagementAgent CapitalAllen & CompanyAnne WojcickiArrowMark Colorado HoldingsArtis VenturesAsset Management VenturesBain Capital Life SciencesBrightEdge FundByers CapitalCRA InternationalCRVCatalio Capital ManagementCormorant Asset ManagementCormorant CapitalDCVCDCVC BioEcoR1 CapitalEventideExact SciencesFarallon Capital ManagementFidelityHBM Healthcare InvestmentsHenderson Global InvestorsInnovation EndeavorsIntermountain VenturesKaiser PermanenteKaiser Permanente VenturesLogos CapitalLongevity Vision FundNovartisPerceptive AdvisorsPolaris PartnersPura Vida InvestmentsQuest DiagnosticsRA Capital ManagementRidgeback Capital ManagementRocheRoche Venture FundRock Springs CapitalS28 CapitalS32Sands Capital ManagementSoleus CapitalSquarepoint CapitalSuvretta Capital ManagementT. Rowe PriceThird Kind Venture CapitalVerilydRx Capital

Funding rounds

Corporate Round
$75MNov 17, 2025
Convertible Note
Exact Sciences
$50MAug 5, 2025
Corporate Round
Exact Sciences
$50MAug 5, 2025
Series F
$254MFeb 15, 2024
Series Unknown
Roche, Intermountain Ventures, Eventide, Squarepoint Capital, Polaris Partners, Bain Capital Life Sciences, RA Capital Management, Cormorant Capital, DCVC Bio, Perceptive Advisors, Quest Diagnostics, Pura Vida Investments, Andreessen Horowitz, Artis Ventures, Sands Capital Management, S32, ArrowMark Colorado Holdings, T. Rowe Price, BrightEdge Fund, ARK Investment Management
$254MFeb 14, 2024
Series E
$290MJan 11, 2022
Corporate Round
Roche
$290MJan 10, 2022
Series D
Perceptive Advisors, RA Capital Management, Andreessen Horowitz, BrightEdge Fund, Catalio Capital Management, Bain Capital Life Sciences, Artis Ventures, Cormorant Capital, DCVC, Fidelity, Farallon Capital Management, Henderson Global Investors, Kaiser Permanente, Novartis, Ridgeback Capital Management, Polaris Partners, Roche Venture Fund, Rock Springs Capital, S32, Sands Capital Management, T. Rowe Price, Soleus Capital, ArrowMark Colorado Holdings, HBM Healthcare Investments, Byers Capital, Eventide, Intermountain Ventures, Suvretta Capital Management, Logos Capital, Pura Vida Investments, GV
$300MDec 6, 2021
Series C
Bain Capital Life Sciences, Perceptive Advisors, RA Capital Management, Farallon Capital Management, Fidelity, Henderson Global Investors, BrightEdge Fund, Catalio Capital Management, Cormorant Asset Management, EcoR1 Capital, Rock Springs Capital, Andreessen Horowitz, Sands Capital Management, DCVC, Novartis, GV, Soleus Capital, Roche Venture Fund, Kaiser Permanente Ventures, S32, Polaris Partners, T. Rowe Price
$270MAug 25, 2020
Series B
Polaris Partners, RA Capital Management, T. Rowe Price, Perceptive Advisors, Verily, S32, BrightEdge Fund, Andreessen Horowitz, DCVC, Kaiser Permanente Ventures, Roche Venture Fund, GV, Longevity Vision Fund, Soleus Capital, Artis Ventures, dRx Capital
$160MJul 23, 2019
Series A
S32, Anne Wojcicki, Andreessen Horowitz, Asset Management Ventures, DCVC, Founders Fund, Innovation Endeavors, Polaris Partners, S28 Capital, Verily, GV, CRV
$7MAug 27, 2017
Series A
Andreessen Horowitz, GV, Polaris Partners, Innovation Endeavors, S28 Capital, Asset Management Ventures, CRA International, AME Cloud Ventures, Allen & Company, DCVC, Founders Fund, Agent Capital
$65MFeb 28, 2017
Seed
Andreessen Horowitz, Founders Fund, DCVC, Third Kind Venture Capital
$5.6MJun 8, 2016

Funding data via Diffbot

Categorized in

Industry

Healthcare & Biotech Biotech & Drug Discovery Health Infrastructure

Investors

Founders Fund Gv Andreessen Horowitz

Industries

Software Companies Medical Organizations Health Care Companies Biotechnology Companies

Tech Stack

Mysql Php Python Wordpress Google Cloud Platform

LOCATIONS

Where they work

Freenome offices

Loading map…

Brisbane, CA
South San Francisco, CA259 E Grand Av